Decoding GNB1E: Advanced Drug Repurposing for Personalized Treatment
Fördersumme: € 999.979
Predicting the evolution of relapse in Wilms tumour using drug sensitivity profiling and liquid biopsies
Fördersumme: € 999.538
Simultaneous assessment of muscle perfusion and mitochondrial function in ME/CFS
Fördersumme: € 40.000
Promt: Probably the Best Moment to Terminate
Dauer: 48 Monate, Fördersumme: € 879.423
Verifying Without Loss of Generality
Dauer: 48 Monate, Fördersumme: € 635.107
Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Dauer: 48 Monate, Fördersumme: € 899.099